We showed previously that there is no significant difference in the expression of the APP between the familial AD and control group [19] and there was also no significant difference in the expression of the neuronal marker MAP2 (p = 0.188), indicating that the reduction in BIN1 is not caused by neuronal loss. The gene discussed is MAP2; the disease is Alzheimer disease.